+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Carbapenemase Diagnostics Market 2024: Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - US, Europe, Japan - Hospitals, Commercial and Public Health Labs, POC Locations

  • PDF Icon

    Report

  • August 2024
  • Region: Europe, Japan, United States
  • VPG Market Research
  • ID: 5995553
Description Jump to:
The report presents a detailed analysis of the Carbapenemase diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology are reviewed.

The report provides the 5-year test volume and sales forecasts by country for the following market segments:
  • Hospitals
  • Commercial/Private Labs
  • Physician Offices
  • Public Health Labs

Related Topics

Related Reports

2024-2028 Global Carbapenemase Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation - Product Image

2024-2028 Global Carbapenemase Testing in 90 Countries: Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • Report
  • Global
From
2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures - Hospitals, Blood Banks, Commercial Labs, POC Locations - Product Image

2024 Global Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures - Hospitals, Blood Banks, Commercial Labs, POC Locations

  • Report
  • 320 Pages
  • Global
From
Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization - Product Image

Syndromic Multiplex Diagnostic Markets with COVID-19 Impacts. Strategies and Trends, Forecasts by Syndrome (Respiratory, Sepsis, GI Etc.), by Country, with Market Analysis, Executive Guides and Customization

  • Report
  • 501 Pages
  • Global
From
Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With Analysis and Executive Guides 2024 - 2028 - Product Image

Molecular Diagnostics for Infectious Disease By Syndrome, Plex, Place and by Country. With Analysis and Executive Guides 2024 - 2028

  • Report
  • 670 Pages
  • Global
From
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 2024 - Product Image

The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 2024

  • Report
  • 620 Pages
  • Global
From

About the Carbapenemase Test Market

The Carbapenemase Test market is a subset of the Infectious Disease Testing market. It is used to detect the presence of carbapenemase enzymes, which are produced by certain bacteria and can cause antibiotic resistance. The test is used to identify the presence of these enzymes in order to determine the best course of treatment for a patient. It is also used to monitor the spread of antibiotic-resistant bacteria in a population. The Carbapenemase Test market is composed of a variety of companies that provide testing services and products. These include companies such as bioMérieux, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. These companies offer a range of products, including test kits, reagents, and instruments. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.